Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression
Recruiting · NCT05801471 · Observational (researchers observe without assigning treatment) · Lead sponsor: Centervue SpA
View the official record on ClinicalTrials.gov →What this trial is about
The purpose of this observational study is to collect over time a series of data in patients with glaucoma in order to evaluate different approaches in defining the progression of this pathology. These data will be collected in repeated visits over a 36-months follow-up period. At each visit, the COMPASS fundus perimeter and the Humphrey Field Analyzer (HFA) perimeter will be used to assess retinal functionality; an Optical Coherence Tomography (OCT) examination will also be performed to evaluate and obtain clinical information about the structure of the retina.
Who can take part
Inclusion criteria
- Glaucomatous optic nerve head in both eyes;
- Age between 40 and 90 years;
- Best Corrected Visual Acuity ≤ 0.3 \[logMar\];
- Spherical refraction between -6D and +6D;
- Astigmatism between -2D and +2D.
Exclusion criteria
- Any ocular surgery, except for: uncomplicated cataract surgery and/or glaucoma surgery in both eyes performed within 6 months before enrollment;
- Any ocular pathology that can affect visual field other than glaucoma;
- Use of any drug that can interfere with the correct execution of perimetry or that would produce visual field loss;
- Inability to obtain reliable perimetric examinations;
- Patients with advanced glaucoma for whom, according to the clinician, a 24-2 grid is not advisable to correctly monitor the patient.
Where it is running
2 locations listed.
- Clinica oculistica Ospedale San Paolo - Milan, Milano, Italy
- Glaucoma Research Center, IRCCS Fondazione "G.B. Bietti" - Roma, Roma, Italy